CTOs on the Move

Tunstall

www.tunstall.com

 
From its founding in 1777 as California`s first city, San José has been a leader driven by its spirit of innovation. Today, San José stands as the largest city in Northern California and the Capital of Silicon Valley—the world`s leading center of technology innovation. San José is the 10th largest in the U.S., and is committed to remaining a top-ranked place to do business, work, live, play and learn. San José is located in Santa Clara County at the southern edge of the San Francisco Bay, about 50 miles south of San Francisco, 390 miles north of Los Angeles. The ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.tunstall.com
  • 1672 Barrington Street Suite 300
    Halifax, NS CAN B3J 2A2
  • Phone: 902.423.2032

Executives

Name Title Contact Details
Gary Steen
Group Chief Technology Officer Profile

Similar Companies

National Decision Support Company

NDSC`s solutions are widely adopted and in use across the entire healthcare provider market in all 50 states and Europe. Organizations ranging from large, multi-state, integrated delivery networks to standalone ambulatory care settings, caregivers trust NDSC CareSelect™ platform to manage and track the actionable delivery of thousands of evidence-based guidelines.

Core Health & Fitness

Core Health & Fitness is more than gym equipment, we offer innovative solutions for all your facility needs. This is why we’ve brought together five of the most recognizable fitness brands to ensure our customers can offer their members authentic fitne...

Parastar

Parastar is a Southfield, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TimelyMD

TimelyCare is a virtual health and well-being platform that provides college and university students with access to 24/7 mental, emotional, and physical care from anywhere.

Fibrocell Science

Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.